Search research articles
Contact Us
Filters
Showing results (201-210 of 239) with videos related to
Page
of 24
Sort By:
The Journal of Biological Chemistry
|
March 30, 2002
A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists
Wen-Bo Zhang, Jean-Marc Navenot, Bodduluri Haribabu, et al.
Plos One
|
October 3, 2012
Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model
Simone Buraschi, Thomas Neill, Rick T Owens, et al.
Journal of Molecular Biology
|
September 6, 2000
Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization
Q Hu, J O Trent, G D Tomaras, et al.
Biochemical and Biophysical Research Communications
|
March 12, 2004
Metastin and its variant forms suppress migration of pancreatic cancer cells
Toshihiko Masui, Ryuichiro Doi, Tomohiko Mori, et al.
Journal of Virology
|
November 2, 2001
Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection
R Tanaka, A Yoshida, T Murakami, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 10, 2008
Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach
Satoshi Ueda, Manabu Kato, Shinsuke Inuki, et al.
International Journal of Cancer
|
December 30, 2009
Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4
Koji Nishizawa, Hiroyuki Nishiyama, Shinya Oishi, et al.
Journal of Virology
|
October 29, 1997
Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein
R Bron, P J Klasse, D Wilkinson, et al.
The Journal of Clinical Investigation
|
October 1, 1986
Molecular cloning, expression, and chromosomal localization of the gene encoding a human myeloid membrane antigen (gp150)
A T Look, S C Peiper, M B Rebentisch, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 28, 2022
Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway
Xiang Li, Shaomin Wang, Wei Mu, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 239) with videos related to
Sort By:
Page
of 24
The Journal of Biological Chemistry
|
March 30, 2002
A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists
Wen-Bo Zhang, Jean-Marc Navenot, Bodduluri Haribabu, et al.
Plos One
|
October 3, 2012
Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model
Simone Buraschi, Thomas Neill, Rick T Owens, et al.
Journal of Molecular Biology
|
September 6, 2000
Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization
Q Hu, J O Trent, G D Tomaras, et al.
Biochemical and Biophysical Research Communications
|
March 12, 2004
Metastin and its variant forms suppress migration of pancreatic cancer cells
Toshihiko Masui, Ryuichiro Doi, Tomohiko Mori, et al.
Journal of Virology
|
November 2, 2001
Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection
R Tanaka, A Yoshida, T Murakami, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 10, 2008
Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach
Satoshi Ueda, Manabu Kato, Shinsuke Inuki, et al.
International Journal of Cancer
|
December 30, 2009
Fluorescent imaging of high-grade bladder cancer using a specific antagonist for chemokine receptor CXCR4
Koji Nishizawa, Hiroyuki Nishiyama, Shinya Oishi, et al.
Journal of Virology
|
October 29, 1997
Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein
R Bron, P J Klasse, D Wilkinson, et al.
The Journal of Clinical Investigation
|
October 1, 1986
Molecular cloning, expression, and chromosomal localization of the gene encoding a human myeloid membrane antigen (gp150)
A T Look, S C Peiper, M B Rebentisch, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 28, 2022
Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway
Xiang Li, Shaomin Wang, Wei Mu, et al.
Page
of 24